A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

Clinical trial NCT06600789 · RECRUITING

Trial details

NCT number: NCT06600789
Sponsor: Carrick Therapeutics Limited
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Malignancies

Start date: 2024-08-16
Primary completion: 2026-04-22
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.